The novel biosynthetic pathway of tetrahydrobiopterin
四氢生物蝶呤的新型生物合成途径
基本信息
- 批准号:14570776
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Tetrahydrobiopterin (BH_4) is a cofactor for aromatic amino acid hydroxylases and nitric oxide synthase. The biosynthesis includes two reduction steps catalyzed by sepiapterin reductase. However, patients with sepiapterin reductase deficiency show normal urinary excretion of pterins without hyperphenylalaninemia, suggesting that other enzymes catalyze the two reduction steps. In this research, the reductase activities for the tetrahydropterin intermediates were examined using several human recombinant enzymes belonging to the aldo-keto reductase (AKR) family. In the reduction of PPH_4 by AKR family enzymes, 2'-OXPH_4 was formed by 3α-hydroxysteroid dehydrogenase type 2, whereas 1'-OXPH_4 was produced by aldose reductase, aldehyde reductase and 20α-hydroxysteroid dehydrogenase, and both 1'-OXPH_4 and 2'-OXPH_4 were detected as the major and minor products by 3α-hydroxysteroid dehydrogenases (types 1 and 3). The activities of aldose reductase and 3α-hydroxysteroid dehydrogenase type 2 (106 and 35 nmol/mg/min, respectively) were higher than those of the other enzymes (0.2-4.0nmol/mg/min). Aldose reductase reduced 2'-OXPH_4 to BH_4, but the other enzymes were inactive towards both 2-OXPH_4 and 1'-OXPH_4. These results indicate that the tetrahydropterin intermediates are natural substrates of the human AKR family enzymes and suggest a novel alternative pathway from PPH_4 to BH_4, in which 3α-hydroxysteroid dehydrogenase type 2 and aldose reductase work in concert.
四氢生物蝶呤(BH4)是芳香族氨基酸羟基酶和一氧化氮合酶的辅因子。该生物合成包括两个还原步骤,由sepiapterin还原酶催化。然而,sepiapterin还原酶缺乏症患者的尿蝶呤排泄正常,没有高苯丙氨酸血症,这表明其他酶催化了这两个还原步骤。在这项研究中,使用了几种属于醛酮还原酶(AKR)家族的人重组酶来检测四氢蝶呤中间体的还原酶活性。在AKR家族酶对PPH4的还原中,3-α-羟基类固醇脱氢酶2型生成2‘-OXPH4,醛糖还原酶、醛还原酶和20-α-羟基类固醇脱氢酶生成1’-OXPH4,3种α-羟基类固醇脱氢酶(1型和3型)分别检测到1‘-OXPH4和2’-OXPH4为主产物和次要产物。醛糖还原酶和3-α-羟基类固醇脱氢酶的活性(分别为106nmoL/mg/min和35nmoL/mg/min)高于其他酶(0.2nmoL/mg/min和4.0nmol/mg/min)。醛糖还原酶将2‘-OXPh_4还原为BH_4,而其他酶对2-OXPh_4和1’-OXPh_4均无活性。这些结果表明,四氢蝶呤中间体是人AKR家族酶的天然底物,并提出了一种从PPh_4到BH_4的新的替代途径,其中3-α-羟基类固醇脱氢酶2型和醛糖还原酶协同工作。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tetrahydrobiopterin is synthesized from 6-pyruvoyl-tetrahydropterin by the human aldo-keto reductase AKR1 family members
- DOI:10.1016/s0003-9861(03)00295-9
- 发表时间:2003-08-15
- 期刊:
- 影响因子:3.9
- 作者:Iino, T;Tabata, M;Hara, A
- 通讯作者:Hara, A
Hiroshi Sawada: "Molecular cloning and characterization of a encoding a novel cuticle protein in the silkworm, Bombyx mori"Comparative Biochemistry and Physiology Part B. (in press). (2003)
Hiroshi Sawada:“家蚕 Bombyx mori 中编码新型角质层蛋白的分子克隆和表征”比较生物化学和生理学 B 部分(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Molecular cloning and characterization of a encoding a novel cuticle protein in the silkworm, Bombyx mori
家蚕(Bombyx mori)编码新型角质层蛋白的分子克隆和表征
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Tanaka H;Mallgborg P;Terashima S;Borres MP.;HIROSHI SAWADA
- 通讯作者:HIROSHI SAWADA
Possibility of the nonenzymatic conversion of 6-(1'-oxo-2'-hydroxypropyl)-tetrahydropterin to sepiapterin
6-(1-氧代-2-羟丙基)-四氢蝶呤非酶转化为墨蝶呤的可能性
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Hida;M.et al.;TERUHIKO IINO
- 通讯作者:TERUHIKO IINO
Possibility of the nonenzymatic Conversion of 6-(1'-oxo-2'-hydroxypropyl)-tetrahydro-pterin to sepiapterin
6-(1-氧代-2-羟丙基)-四氢蝶呤非酶转化为墨蝶呤的可能性
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Kanemoto;K.et al.;Teruhiko Iino
- 通讯作者:Teruhiko Iino
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IINO Teruhiko其他文献
IINO Teruhiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IINO Teruhiko', 18)}}的其他基金
Expression analysis of the aldo-keto reductases involved in the novel biosynthetic pathway of tetrahydrobiopterin in human and mouse tissues
人和小鼠组织中参与四氢生物蝶呤新生物合成途径的醛酮还原酶的表达分析
- 批准号:
18591170 - 财政年份:2006
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study of novel biosynthetic pathway of BH_4 which concern human aldo-keto reductases
人醛酮还原酶BH_4新生物合成途径的研究
- 批准号:
16591059 - 财政年份:2004
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relationship of atypical phenylketonuria and a new type of carbonyl reductase which related to synthesize BH4
非典型苯丙酮尿症与合成BH4的新型羰基还原酶的关系
- 批准号:
12670785 - 财政年份:2000
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Occurrence of a New Tetrahydrobiopterin Synthesizing enzyme in the human being
人类体内新型四氢生物蝶呤合成酶的出现
- 批准号:
10670765 - 财政年份:1998
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
卵巣明細胞癌に対するCarbonyl reductase 1遺伝子治療の有効性
羰基还原酶1基因治疗卵巢透明细胞癌的疗效
- 批准号:
22K16848 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapeutic strategy of advanced ovarian cancer by targeting carbonyl reductase 1
以羰基还原酶1为靶点的晚期卵巢癌治疗策略
- 批准号:
20K09589 - 财政年份:2020
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel therapeutic method for uterine cervical cancer by Arsenic trioxide via inducing Carbonyl reductase 1
三氧化二砷诱导羰基还原酶1治疗宫颈癌的新方法
- 批准号:
20K18222 - 财政年份:2020
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanism of inhibitory effect of Carbonyl reductase on cancers aiming to gene therapy
羰基还原酶对癌症基因治疗的抑制作用机制
- 批准号:
26462508 - 财政年份:2014
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of carbonyl reductase function -development of the new molecular target therapy-
羰基还原酶功能分析-新型分子靶向治疗的开发-
- 批准号:
23592452 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Carbonyl reductase-based production of enantipure alcohol libraries for use as pharmaceutical building blocks
基于羰基还原酶的对映纯醇库的生产,用作药物构建模块
- 批准号:
130236 - 财政年份:2010
- 资助金额:
$ 2.05万 - 项目类别:
BEIS-Funded Programmes
STRUCT/FUNCT ANALYSIS OF ANTHRACYCLINE REDUCTION BY HUMAN CARBONYL REDUCTASE
人羰基还原酶还原蒽环类化合物的结构/功能分析
- 批准号:
7959934 - 财政年份:2009
- 资助金额:
$ 2.05万 - 项目类别:
STRUCT/FUNCT ANALYSIS OF ANTHRACYCLINE REDUCTION BY HUMAN CARBONYL REDUCTASE
人羰基还原酶还原蒽环类化合物的结构/功能分析
- 批准号:
7720019 - 财政年份:2008
- 资助金额:
$ 2.05万 - 项目类别:
STRUCT/FUNCT ANALYSIS OF ANTHRACYCLINE REDUCTION BY HUMAN CARBONYL REDUCTASE
人羰基还原酶还原蒽环类化合物的结构/功能分析
- 批准号:
7609920 - 财政年份:2007
- 资助金额:
$ 2.05万 - 项目类别:
STRUCT/FUNCT ANALYSIS OF ANTHRACYCLINE REDUCTION BY HUMAN CARBONYL REDUCTASE
人羰基还原酶还原蒽环类化合物的结构/功能分析
- 批准号:
7381311 - 财政年份:2006
- 资助金额:
$ 2.05万 - 项目类别:














{{item.name}}会员




